Both regular and “diet” soft drinks may be far worse for liver health than believed. A massive study of over 120,000 ...
FITBOOK magazine on MSN
Liver Cancer–Early Signs, Causes, and Treatment
Liver cancer is considered one of the rarer types of cancer in Germany, but the number of new cases is increasing. The ...
Detailed price information for Monopar Therapeutics Inc (MNPR-Q) from The Globe and Mail including charting and trades.
6d
Nanoparticles show potential for halting inflammation and scarring in alcohol-related liver disease
Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease Control and Prevention reports that it kills more than 52,000 people a year in the United ...
8don MSN
Liver disease breakthrough as scientists discover two common medications can REVERSE condition
Spanish scientists have found that combining a drug to tackle high cholesterol and one for high blood pressure, could ...
Copper bottles offer antimicrobial benefits and essential trace minerals, but excessive intake can be harmful. Individuals ...
Monopar Therapeutics stock has surged 2,000% with ALXN-1840's potential and promising MNPR-101-Zr data. Here's what investors ...
AstraZeneca abandoned a rare disease drug, but a co-inventor believes the company made a formula error in analyzing clinical ...
Sugary and artificially sweetened drinks both increase the risk of liver disease, suggests a new study. Sugar-sweetened beverages (SSBs) and low- or non-sugar-sweetened beverages (LNSSBs) are ...
Drinking as little as one can of diet soda a day may increase the risk of non-alcoholic fatty liver disease by 60%, while drinking a sugary beverage could raise the risk by 50%, a new unpublished ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback